Eledon Pharmaceuticals, Inc. (ELDN) Q4 2024 Annual Earnings
ELDN·Reported March 20, 2025·Before market open
Eledon Pharmaceuticals, Inc. reported Q4 2024 revenue of $192.0K. Diluted EPS came in at $-0.64, missed the $-0.32 consensus by $0.32.
Revenue
$192.0K
Diluted EPS
$-0.64missed by $0.32
Consensus: $-0.32
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Eledon Pharmaceuticals, Inc.'s Q4 2024 earnings report.
Eledon Pharmaceuticals, Inc. (ELDN) reported Q4 2024 earnings on March 20, 2025 before market open.
Eledon Pharmaceuticals, Inc. reported revenue of $192.0K and diluted EPS of $-0.64 for Q4 2024.
EPS missed the consensus estimate of $-0.32 by $0.32.
You can read the 10-K periodic report (0000950170-25-042754) directly on SEC EDGAR. The filing index links above go to sec.gov.